Sanctuary Advisors LLC Purchases New Shares in Tilray Inc (NASDAQ:TLRY)

Sanctuary Advisors LLC acquired a new position in Tilray Inc (NASDAQ:TLRY) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 36,664 shares of the company’s stock, valued at approximately $65,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Tidal Investments LLC increased its stake in shares of Tilray by 36,687.0% in the 1st quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after acquiring an additional 10,648,403 shares in the last quarter. Vanguard Group Inc. grew its holdings in Tilray by 3.5% in the first quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after purchasing an additional 117,891 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Tilray by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after purchasing an additional 213,834 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after purchasing an additional 355,778 shares during the last quarter. Finally, Swiss National Bank boosted its position in shares of Tilray by 3.6% in the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock worth $3,683,000 after purchasing an additional 51,700 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Stock Down 0.6 %

Shares of TLRY stock opened at $1.58 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. Tilray Inc has a one year low of $1.45 and a one year high of $2.97. The company’s fifty day moving average price is $1.73 and its 200-day moving average price is $1.81. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of -5.85 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The business had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same period last year, the firm earned ($0.10) earnings per share. The business’s quarterly revenue was up 13.0% on a year-over-year basis. Sell-side analysts expect that Tilray Inc will post -0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Roth Mkm dropped their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.